Here are Monday's biggest analyst calls: Nvidia, Micron, Ferrari, Rocket Lab, DataDog & more

Wall Street research notes were broadly constructive, with multiple initiations and upgrades across semis, AI, biotech, aerospace, and software names. Several firms highlighted upside to consensus or new price targets, including Micron at $1,500 from $660, Ferrari to $438 from $388, and Esco Technologies at $420, while a few names such as Old Dominion, C.H. Robinson, and Roku were downgraded on valuation or limited upside. Overall, the article reflects a risk-on analyst tone centered on AI, innovation, and company-specific catalysts.

Analysis

The common thread is not broad risk-on; it is a selective re-rating of “picks-and-shovels” infrastructure where the market has been underpricing operating leverage. The cleanest relative winners are the names with visible install-base or capacity bottlenecks: semicap process control, AI/edge IP, launch capacity, and data-center-adjacent infrastructure. That matters because these businesses can see multiple expansion before fundamentals fully inflect, especially when Street models are still anchored to linear growth assumptions.

The transportation downgrades are a useful tell: investors have been paying up for peak-cycle quality in freight, but the setup is now asymmetric to the downside if volume/margin normalization continues while expectations remain elevated. This creates a second-order winner in any industrial/consumer basket that is effectively short logistics beta via lower input and delivery costs, while shippers and asset-heavy trucking names are vulnerable to even modest demand deceleration. The market is also likely misreading the difference between “defensive” and “non-cyclical”: several healthcare and software calls are really about margin inflection, not just safety.

The most interesting contrarian point is that several of the strongest calls are in crowded narratives: AI, space, crypto adjacency, and “self-help” turnaround stories. Those can still work, but the entry point matters because the multiple is often doing most of the work early; a disappointment in guidance cadence, monetization timing, or capital intensity could compress these names faster than the underlying thesis breaks. In contrast, the most underappreciated upside may be in the more boring compounders where the sell-side is finally catching up to operational inflection, such as payroll, infrastructure test equipment, and payments.

Key Decisions for Investors

• Go long RKLB and FLY for 3-6 months, but size via a spread: long the better catalyst-to-valuation ratio and hedge with a basket short of high-multiple aerospace/defense proxies. Risk/reward is favorable if launch-capacity shortages persist; trim if the market starts capitalizing the SpaceX IPO story into the entire group.
• Pair long ODFL/CHRW/SAIA/KNX underperformance against a basket of industrial beneficiaries over the next 1-2 quarters. The freight call implies valuation compression can happen before fundamentals roll over, and the downside is sharper if rates or volumes decelerate further.
• Buy NVDA on pullbacks, but express it with upside calls 6-12 months out rather than spot equity. The thesis is that enterprise AI and physical AI extend the growth runway, but the stock remains vulnerable to any near-term digestion in capex headlines.
• Initiate a relative-value long COF vs short a consumer-credit-sensitive lender basket for 6 months. The market is over-penalizing consumer weakness while underweighting capital return flexibility; this should outperform if charge-offs stay orderly and buybacks resume aggressively.
• Add PAYX and DDOG on weakness over the next 1-2 quarters as earnings revisions are likely to lag the operating inflection. Both can re-rate without heroic top-line acceleration if investors believe the next leg is margin and retention-driven.